Safety
The product does not contain stem cells. Exosomes are products of cellular activity. According to experts, exosome therapy is safer and more promising than cell therapy.
There are clinical studies of exosomes in various nosologies (ARDS, lung infections, COVID-19, depression, anxiety, dementia, skin wound healing, acute ischemic stroke, bullous dystrophic epidermolysis) all over the world. Note that exosomes can be used not only in cosmetology, but also in other medical fields where there is an abnormal inflammatory response (cytokine storm, autoimmune diseases) or where it is necessary to accelerate the regeneration process (burns, fractures, etc.).
Publications
1. Clinical studies of exosomes in various nosologies are taking place all over the world
- A Clinical Study of Mesenchymal Stem Cell Exosomes Nebulizer for the Treatment of ARDS (ClinicalTrials.gov Identifier: NCT04602104);
- A Clinical Study of Mesenchymal Progenitor Cell Exosomes Nebulizer for the Treatment of Pulmonary Infection (ClinicalTrials.gov Identifier: NCT04544215);
- COVID-19 Specific T Cell Derived Exosomes (CSTC-Exo) (ClinicalTrials.gov Identifier: NCT04389385);
- A Pilot Clinical Study on Inhalation of Mesenchymal Stem Cells Exosomes Treating Severe Novel Coronavirus Pneumonia (ClinicalTrials.gov Identifier: NCT04276987);
- Focused Ultrasound and Exosomes to Treat Depression, Anxiety, and Dementias (ClinicalTrials.gov Identifier: NCT04202770);
- Effect of Plasma Derived Exosomes on Cutaneous Wound Healing (ClinicalTrials.gov Identifier: NCT02565264);
- Allogenic Mesenchymal Stem Cell Derived Exosome in Patients With Acute Ischemic Stroke (ClinicalTrials.gov Identifier: NCT03384433);
- MSC EVs in Dystrophic Epidermolysis Bullosa (ClinicalTrials.gov Identifier: NCT04173650)